Antidepressant Effects of TS-161 in Treatment-Resistant Depression

计划入组 11 人 · 首次发布于 2021 年 3 月 29 日

A mGlu2/3 Agonist in the Treatment of PTSD

计划入组 10 人 · 首次发布于 2014 年 9 月 9 日

A Study of [11C]JNJ-42491293, a Possible PET Ligand for the mGlu2 Receptor, in Healthy Adult Volunteers

计划入组 20 人 · 首次发布于 2011 年 5 月 25 日

neurotensin receptor 1 antagonist

DL-3

NX-01-R-3

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

3-D Matrix Ltd.

Japan

Llama-Derived Nanobody Shows Promise for Schizophrenia Cognitive Symptoms in Preclinical Study

Denovo Biopharma Partners with Orygen for Phase 2 Trial of Novel Glutamate-Targeting Drug in Early Psychosis

Amylyx Acquires Phase 3-Ready GLP-1 Receptor Antagonist Avexitide for Hyperinsulinemic Hypoglycemia